News
NEW YORK (AP) — U.S. stocks are drifting in mixed trading Tuesday as stronger-than-expected profits keep piling higher for ...
SpringWorks sells two rare tumors drugs in the US and has two precision oncology drugs in early-stage development.
The health sector is navigating various challenges, including debates over drug pricing in the EU, pest agreements between ...
A German pharmaceutical company is acquiring a drug developer with operations in Research Triangle Park.
Trump to offer automakers some relief on his 25% tariffs, after worries they could hurt US factories
WASHINGTON (AP) — President Donald Trump will sign an executive order Tuesday to relax some of his 25% tariffs on autos and ...
MEXICO CITY (AP) — MEXICO CITY (AP) — Grupo Aeroportuario del Centro Norte SAB de CV (OMAB) on Tuesday reported net income of $62.9 million in its first quarter. The Mexico City-based company said it ...
LIMA, Peru (AP) — LIMA, Peru (AP) — Cementos Pacasmayo SAA (CPAC) on Monday reported profit of $14.2 million in its first quarter. The Lima, Peru-based company said it had profit of 16 cents per share ...
Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks ...
Novartis released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, ...
Current health news highlights include a dispute over EU drug pricing proposals, a U.S.-Mexico accord on screwworm management ...
14h
Fintel on MSNBarclays Downgrades SpringWorks Therapeutics (SWTX)Fintel reports that on April 28, 2025, Barclays downgraded their outlook for SpringWorks Therapeutics (NasdaqGS:SWTX) from ...
The loans sat on banks' books for two-and-a-half years until the election of Donald Trump rapidly changed the company's fortunes. International Business Machines plans to invest $150 billion in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results